Email this pagePast Press Releases
This is a list of previous press releases involving research that has been conducted by our department's faculty.
May 7, 2009
Study Reveals Current Multi-Component Vaccines May Need Reworking
Current strategies for designing vaccines against HIV and cancers, for instance, may enable some components in multi-component vaccines to cancel the effect of others on the immune system, eliminating their ability to provide protection, according to an article to be published shortly in the Proceedings of the National Academy of Sciences (PNAS).
April 01, 2009
Stephen Dewhurst to Lead Department of Microbiology & Immunology
After an in-depth, national search, a leading researcher in the design of next-generation vaccines for HIV and influenza has been chosen as the new chair of the Department of Microbiology & Immunology at the University of Rochester Medical Center. The appointment will be effective July 1, 2009, pending approval by the University Trustees.
February 26, 2009
A Worm-and-Mouse Tale: B Cells Deserve More Respect
By studying how mice fight off infection by intestinal worms – a condition that affects more than 2 billion people worldwide – scientists have discovered that the immune system is more versatile than has long been thought. The work with worms is opening a new avenue of exploration in the search for treatments against autoimmune diseases like diabetes and asthma, where the body mistakenly attacks its own tissues.
February 24, 2009
Researchers Block Immune Cell Rush Behind Deadly Sepsis
Researchers have found a way to block the ability of white blood cells to sprint toward the sites of infection when such speed worsens the damage done by sepsis, the often fatal, whole-body bacterial infection, according to a study published today in the journal Blood.
February 06, 2009
$1.9M to Help Explore Why Lupus Therapies Work for Some, Not Others
Bolstered by a five-year, $1.9 million research grant from the National Institutes of Health, Jennifer Anolik, M.D., Ph.D., assistant professor of Medicine and of Pathology and Laboratory Medicine, plans to probe why certain targeted therapies prove effective for some lupus patients, but not others.
January 8, 2009
URMC, Lighthouse Biosciences Awarded U.S. Patent for Diagnostic Technology
The University of Rochester Medical Center (URMC) has received a U.S. patent for a diagnostic technology that can rapidly and accurately screen for organisms such as bacteria and other infectious agents. Lighthouse Biosciences, Inc., a Rochester-based life sciences company, is the exclusive worldwide license holder of the technology.
January 8, 2009
Nose-Spray Vaccine Against Botulism Effective in Early Tests
A preclinical study found a new nasal spray vaccine to provide complete protection against a major botulism toxin, according to a study published today in the Nature journal Gene Therapy.
November 14, 2008
Researchers Identify Toehold for HIV’s Assault on Brain
Scientists have unraveled in unprecedented detail the cascade of events that go wrong in brain cells affected by HIV, a virus whose assault on the nervous system continues unabated despite antiviral medications that can keep the virus at bay for years in the rest of the body.
October 17, 2008
Area Families Sought for Flu Surveillance Study
Beginning immediately, University of Rochester researchers hope to recruit 100 area families for a multi-year surveillance study that aims to better understand how the body fights flu.
September 17, 2008
Gelbard Named Director of Center for Neural Development and Disease
Harris A. Gelbard, M.D., Ph.D., professor of neurology, pediatrics and of microbiology and immunology, has been named director of the Center for Neural Development and Disease at the University of Rochester Medical Center.
August 1, 2008
Renowned Immunologists Join Medical Center
Husband-and-wife scientists who are reshaping the frontiers of immunology are among the first high-profile recruits to join the Medical Center as part of the new strategic plan.
April 11, 2008
Nose Spray Anthrax Vaccine Effective in Early Tests
Early studies show that a new mucosal vaccine against anthrax has the potential to provide military personnel with more effective and efficient protection against a “popular” bioweapon, according to a study published today in the journal Clinical and Vaccine Immunology (CVI).
January 31, 2008
Anti-Parasite Drug Provides New Way to Attack HIV
A drug already used to treat parasitic infections, and once looked at for cancer, also attacks the human immunodeficiency virus (HIV) in a new and powerful way, according to research published today online in the open access journal Retrovirology.
Click here the return to the previous page.
